Bill Text: TX HR77 | 2023-2024 | 88th Legislature | Enrolled
Bill Title: Recognizing February 22, 2023, as Hypertrophic Cardiomyopathy Awareness Day.
Spectrum: Bipartisan Bill
Status: (Passed) 2023-02-22 - Reported enrolled [HR77 Detail]
Download: Texas-2023-HR77-Enrolled.html
H.R. No. 77 |
|
||
WHEREAS, Hypertrophic Cardiomyopathy Awareness Day is taking | ||
place on February 22, 2023, and this occasion provides a fitting | ||
opportunity to promote better understanding of this health issue; | ||
and | ||
WHEREAS, Hypertrophic cardiomyopathy (HCM) is a chronic | ||
cardiovascular disease that involves thickening of the heart muscle | ||
and can potentially lead to debilitating symptoms and serious | ||
complications, including heart failure, atrial fibrillation, | ||
stroke, and in rare cases, sudden cardiac death; and | ||
WHEREAS, HCM is the most common inheritable heart disease; it | ||
can affect anyone, regardless of age, gender, or ethnicity, and it | ||
has a reported prevalence ranging from 1 in 200 individuals to 1 in | ||
500 individuals in the general population; an estimated 58,722 to | ||
146,804 people in Texas have HCM, although approximately 85 percent | ||
of them remain undiagnosed; and | ||
WHEREAS, HCM shares symptoms with other common | ||
cardiovascular and pulmonary diseases, such as shortness of breath, | ||
chest pain, fatigue, palpitations, and fainting, and those | ||
similarities make it difficult to accurately diagnose HCM; in | ||
addition, the all-cause mortality risk is three to four times | ||
higher in patients with HCM than that of the general population; in | ||
order to receive a diagnosis, patients should know their medical | ||
history and stay informed about the signs and symptoms of HCM; and | ||
WHEREAS, Health care providers must conduct thorough | ||
screenings with cardiac health questions to help identify a risk of | ||
both genetic and congenital cardiac disorders; they may also | ||
conduct several tests, including an echocardiogram, a cardiac MRI, | ||
or genetic testing to confirm a family history of HCM, and they must | ||
examine the heart to diagnose HCM; and | ||
WHEREAS, Following a diagnosis of HCM, it is important for | ||
patients to work with their health care providers to learn more | ||
about the disease and different management options, such as | ||
prescription medicines and surgical treatments; and | ||
WHEREAS, Hypertrophic cardiomyopathy is a serious and | ||
life-threatening disease, and the observance of Hypertrophic | ||
Cardiomyopathy Awareness Day unites people around the world in | ||
their commitment to improving the quality of life for patients; | ||
now, therefore, be it | ||
RESOLVED, That the House of Representatives of the 88th Texas | ||
Legislature hereby recognize February 22, 2023, as Hypertrophic | ||
Cardiomyopathy Awareness Day and urge all Texans to learn more | ||
about the disease; and, be it further | ||
RESOLVED, That an official copy of this resolution be | ||
prepared for the Hypertrophic Cardiomyopathy Association as an | ||
expression of high regard by the Texas House of Representatives. | ||
Lalani | ||
______________________________ | ||
Speaker of the House | ||
I certify that H.R. No. 77 was adopted by the House on | ||
February 22, 2023, by a non-record vote. | ||
______________________________ | ||
Chief Clerk of the House | ||